BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castro J, Ribó M, Vilanova M, Benito A. Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents. Pharmaceutics 2021;13:82. [PMID: 33435285 DOI: 10.3390/pharmaceutics13010082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ulyanova V, Nadyrova A, Dudkina E, Kuznetsova A, Ahmetgalieva A, Faizullin D, Surchenko Y, Novopashina D, Zuev Y, Kuznetsov N, Ilinskaya O. Structural and Functional Differences between Homologous Bacterial Ribonucleases. Int J Mol Sci 2022;23:1867. [PMID: 35163789 DOI: 10.3390/ijms23031867] [Reference Citation Analysis]
2 Garnett ER, Raines RT. Emerging biological functions of ribonuclease 1 and angiogenin. Crit Rev Biochem Mol Biol 2021;:1-17. [PMID: 34886717 DOI: 10.1080/10409238.2021.2004577] [Reference Citation Analysis]
3 Liang Y, Furukawa H, Sakamoto K, Inaba H, Matsuura K. Anticancer Activity of Reconstituted Ribonuclease S-Decorated Artificial Viral Capsid. Chembiochem 2022;:e202200220. [PMID: 35676201 DOI: 10.1002/cbic.202200220] [Reference Citation Analysis]
4 Castro J, Tornillo G, Ceada G, Ramos-Neble B, Bravo M, Ribó M, Vilanova M, Smalley MJ, Benito A. A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells. Cancers (Basel) 2021;13:4350. [PMID: 34503160 DOI: 10.3390/cancers13174350] [Reference Citation Analysis]
5 Siraj YA. Promises of eukaryotic ribonucleases for cancer treatment: a systematic review. transl med commun 2022;7. [DOI: 10.1186/s41231-022-00113-9] [Reference Citation Analysis]